Ribavirin
What's New
Last Posted: Apr 10, 2021
- Association between interleukin 28B polymorphism and sustained virological response to sofosbuvir plus daclatasvir in chronic hepatitis C genotype 4 Egyptian patients.
Hassanien Khalid S, et al. Journal of clinical pharmacy and therapeutics 2021 3 - Interferon-? inducible protein-10 and interleukin 28B gene polymorphism as predictive markers for genotype 4 hepatitis C virus treatment response.
Abd El-Maksoud E, et al. Tropical biomedicine 2020 12 (4) 1083-1092 - Association of macrophage inhibitory factor -1 polymorphisms with antiviral efficacy of type 1b chronic hepatitis C.
Ye Songdao, et al. Molecular and cellular biochemistry 2021 2 - Pharmacogenomics of COVID-19 therapies.
Takahashi Takuto et al. NPJ genomic medicine 2020 Aug 5(1) 35 - Interleukin-17 haplotyping predicts hepatocellular carcinoma in Sofosbuvir, Pegylated interferon-alpha-2a & Ribavirin treated chronic hepatitis C patients.
Mostafa Ahmed M, et al. Virus research 2020 11 198226 - Pharmacogenomics of COVID-19 therapies
T Takahashi et al, NPJ Genomic Medicine, August 18, 2020 - Association between inosine triphosphatase rs1127354 polymorphisms and ribavirin-induced anaemia and outcome in hepatitis C virus-infected patients: A meta-analysis.
Ma Zhichao, et al. Journal of clinical pharmacy and therapeutics 2020 7 - Impact of IL28B gene polymorphism on efficacy and safety of direct acting antivirals in hepatitis C Egyptian patients.
Ebid Abdel-Hameed Ibrahim Mohamed, et al. International journal of clinical pharmacy 2020 7 - Predictive power of Interleukin-28B gene variants for outcome of Hepatitis C Virus genotype 4 in Egyptians: A systematic review and meta-analysis.
El-Fattah Mohamed Abd, et al. Clinics and research in hepatology and gastroenterology 2020 7 - Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study
E Lawitz et al, ancet Gastro Hepato, June 9, 2020
More
About PGx PHGKB
PGx PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to medications....more
Content Summary
Common PGx Related Topics
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 26, 2021
- Content source: